All In Biotech

Drug Trial Radar · NCT04586660

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

An Open-label, Multi-center, Phase 4 Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Last checked: Nov 20, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

36

Actual

Start

Aug 17, 2023

Primary completion

Mar 7, 2028

Study completion Mar 7, 2028

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 14, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aims to evaluate the efficacy of XGEVA® in Chinese participants with giant cell tumor of bone (GCTB).

Conditions

  • Giant Cell Tumor of Bone

Interventions

  • XGEVA®Drug

    Participants will receive XGEVA® 120 mg subcutaneously (SC) once every 4 weeks (Q4W) with a loading dose of 120 mg SC on day 8 and day 15.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective tumor responseTime frame: Up to 36 months

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Beijing Jishuitan Hospital

    Beijing, Beijing Municipality, China

  • Peking University Peoples Hospital

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China

  • The Third Affiliated Hospital Of Southern Medical University

    Guangzhou, Guangdong, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China

  • Harbin Meidical University Cancer Hospital

    Harbin, Heilongjiang, China

  • Tangdu Hospital of Air Force Medical University

    Xi'an, Shaanxi, China

  • The Second Affiliated hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.